$AGRI
AGRIFORCE GROWING SYSTEMS LTD. Stock $agri

$agri Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000149315224031696 Filed on August 13, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2023 Q2
Revenue		$41.32K	$0.00
YoY Change
Cost Of Revenue		$33.73K
YoY Change
Gross Profit		$7.584K
YoY Change
Gross Profit Margin		18.36%
Selling, General & Admin	$305.5K	$335.7K	$355.5K
YoY Change	50.42%	-5.59%	-5.68%
% of Gross Profit		4425.82%
Research & Development	$54.04K	$509.00	$13.24K
YoY Change	-299.79%	-96.15%	-56.36%
% of Gross Profit		6.71%
Depreciation & Amortization	$169.3K	$162.9K	$171.8K
YoY Change	-0.44%	-5.18%	3044.37%
% of Gross Profit		2148.47%
Operating Expenses	$5.605M	$1.176M	$368.8K
YoY Change	3084.47%	218.87%	-9.45%
Operating Profit	-$5.605M	-$1.168M	-$2.914M
YoY Change	243.67%	-59.9%	-30.98%
Interest Expense	-$631.0K	-$806.8K	-$2.074M
YoY Change	-69.81%	-61.11%	-2104.83%
% of Operating Profit
Other Income/Expense, Net	$314.0K	-$369.1K	$2.461M
YoY Change	36.51%	-115.0%	264.33%
Pretax Income	-$5.847M	-$4.232M	-$2.527M
YoY Change	67.55%	67.48%	-26.6%
Income Tax
% Of Pretax Income
Net Earnings	-$5.847M	-$4.232M	-$2.527M
YoY Change	67.4%	67.48%	-26.6%
Net Earnings / Revenue		-10243.49%
Basic Earnings Per Share	-$0.06	-$0.09	-$0.10
Diluted Earnings Per Share	-$0.06	-$0.09	-$0.10
COMMON SHARES
Basic Shares Outstanding	92.34M shares	22.57M shares	18.52M shares
Diluted Shares Outstanding	92.02M shares	45.88M shares	499.5K shares

Balance Sheet

Concept	2024 Q3	2024 Q2	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.373M	$2.938M	$1.229M
YoY Change	69.54%	139.03%	-38.46%
Cash & Equivalents	$1.373M	$2.937M	$1.005M
Short-Term Investments			$223.6K
Other Short-Term Assets	$74.94K	$18.99K	$198.0K
YoY Change	-70.02%	-90.41%	77.12%
Inventory	$47.17K	$4.621K
Prepaid Expenses	$280.3K	$136.2K	$88.60K
Receivables	$163.00	$8.479K	$61.80K
Other Receivables	$23.65K	$25.21K	$61.80K
Total Short-Term Assets	$1.944M	$3.273M	$1.489M
YoY Change	67.52%	119.88%	-89.42%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.612K	$3.574K	$101.3K
YoY Change	-97.18%	-96.47%	-17.39%
Goodwill	$314.4K
YoY Change
Intangibles	$8.370M	$11.98M	$13.06M
YoY Change	-33.68%	-8.23%	42.09%
Long-Term Investments		$216.3K
YoY Change
Other Assets	$48.21K	$78.89K	$0.00
YoY Change
Total Long-Term Assets	$8.848M	$12.39M	$16.74M
YoY Change	-45.3%	-25.97%	27.6%
TOTAL ASSETS
Total Short-Term Assets	$1.944M	$3.273M	$1.489M
Total Long-Term Assets	$8.848M	$12.39M	$16.74M
Total Assets	$10.79M	$15.66M	$18.23M
YoY Change	-37.75%	-14.06%	-32.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$612.1K	$409.1K	$574.2K
YoY Change	-1.89%	-28.75%	-57.14%
Accrued Expenses	$962.5K	$875.4K	$445.6K
YoY Change	44.58%	96.43%	300.98%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.094M	$925.9K	$5.175M
YoY Change	-76.58%	-82.11%	39.96%
Total Short-Term Liabilities	$3.160M	$2.642M	$7.010M
YoY Change	-53.94%	-62.31%	0.09%
LONG-TERM LIABILITIES
Long-Term Debt	$44.45K	$43.84K	$45.32K
YoY Change	11.13%	-3.27%	-2.66%
Other Long-Term Liabilities	$25.17K	$1.656M	$3.863M
YoY Change	-99.18%	-57.14%	-61.33%
Total Long-Term Liabilities	$25.17K	$1.700M	$3.908M
YoY Change	-99.19%	-56.51%	-61.06%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.160M	$2.642M	$7.010M
Total Long-Term Liabilities	$25.17K	$1.700M	$3.908M
Total Liabilities	$4.122M	$4.342M	$10.92M
YoY Change	-58.72%	-60.23%	-35.93%
SHAREHOLDERS EQUITY
Retained Earnings	-$57.91M	-$52.07M	-$37.02M
YoY Change	42.95%	40.64%	39.05%
Common Stock	$62.13M	$61.09M	$33.09M
YoY Change	48.31%	84.62%	23.87%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$6.669M	$11.32M	$7.309M
YoY Change
Total Liabilities & Shareholders Equity	$10.79M	$15.66M	$18.23M
YoY Change	-37.75%	-14.06%	-32.95%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2023 Q2
OPERATING ACTIVITIES
Net Income	-$5.847M	-$4.232M	-$2.527M
YoY Change	67.4%	67.48%	-26.6%
Depreciation, Depletion And Amortization	$169.3K	$162.9K	$171.8K
YoY Change	-0.44%	-5.18%	3044.37%
Cash From Operating Activities	-$1.201M	-$919.2K	-$1.692M
YoY Change	9.15%	-45.68%	-22.64%
INVESTING ACTIVITIES
Capital Expenditures			$0.00
YoY Change			-100.0%
Acquisitions
YoY Change
Other Investing Activities	-$356.1K
YoY Change
Cash From Investing Activities	-$356.1K		$0.00
YoY Change			-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	1.082M	-11.40K
YoY Change	-100.0%	-9589.74%	-67.43%
NET CHANGE
Cash From Operating Activities	-1.201M	-919.2K	-1.692M
Cash From Investing Activities	-356.1K		0.000
Cash From Financing Activities	0.000	1.082M	-11.40K
Net Change In Cash	-1.557M	162.6K	-1.704M
YoY Change	238.42%	-109.55%	-27.96%
FREE CASH FLOW
Cash From Operating Activities	-$1.201M	-$919.2K	-$1.692M
Capital Expenditures			$0.00
Free Cash Flow			-$1.692M
YoY Change			-17.25%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	us-gaap	Common Stock Shares Authorized Unlimited CommonStockSharesAuthorizedUnlimited	Unlimited
	us-gaap	Common Stock Shares Authorized Unlimited CommonStockSharesAuthorizedUnlimited	Unlimited
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	75826	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	162326	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001826397
	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q4	AGRI	Lease Deposit Noncurrent Assets LeaseDepositNoncurrentAssets	63708	usd
CY2023Q4	AGRI	Construction In Progress ConstructionInProgress	113566	usd
CY2023Q4	us-gaap	Investments And Other Noncurrent Assets InvestmentsAndOtherNoncurrentAssets	223801	usd
CY2023Q4	us-gaap	Assets Assets	17367927	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1942011	usd
CY2023Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	4084643	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	15336	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6041990	usd
CY2023Q4	us-gaap	Lease Deposit Liability LeaseDepositLiability	25684	usd
CY2023Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	2690308	usd
CY2023Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	45365	usd
CY2023Q4	us-gaap	Liabilities Liabilities	8803347	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	49828942	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3472444	usd
CY2023Q4	AGRI	Obligation To Issue Shares ObligationToIssueShares	97094	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-44507304	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-326596	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	8564580	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	17367927	usd
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	A1
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	00-0000000
CY2024Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent		usd
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold		usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold		usd
CY2023Q2	us-gaap	Gross Profit GrossProfit		usd
	us-gaap	Gross Profit GrossProfit		usd
CY2023Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2024Q2	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense		usd
CY2023Q2	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense		usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense		usd
CY2024Q2	us-gaap	Inventory Write Down InventoryWriteDown		usd
CY2023Q2	us-gaap	Inventory Write Down InventoryWriteDown		usd
	us-gaap	Inventory Write Down InventoryWriteDown		usd
CY2024Q2	AGRI	Write Off Of Deposit WriteOffOfDeposit		usd
CY2023Q2	AGRI	Write Off Of Deposit WriteOffOfDeposit		usd
	AGRI	Write Off Of Deposit WriteOffOfDeposit		usd
CY2024Q2	AGRI	Stock Issued During Period Value Conversion Of Vested Prefunded Warrants StockIssuedDuringPeriodValueConversionOfVestedPrefundedWarrants		usd
	AGRI	Stock Issued During Period Value Conversion Of Vested Prefunded Warrants StockIssuedDuringPeriodValueConversionOfVestedPrefundedWarrants		usd
CY2023Q2	AGRI	Stock Issued During Period Value Conversion Of Vested Prefunded Warrants StockIssuedDuringPeriodValueConversionOfVestedPrefundedWarrants		usd
	AGRI	Stock Issued During Period Value Conversion Of Vested Prefunded Warrants StockIssuedDuringPeriodValueConversionOfVestedPrefundedWarrants		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
	AGRI	Write Off Of Deposit WriteOffOfDeposit		usd
	us-gaap	Other Noncash Expense OtherNoncashExpense		usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense		usd
	AGRI	Increase Decrease In Lease Deposit Asset IncreaseDecreaseInLeaseDepositAsset		usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability		usd
	AGRI	Increase Decrease In Rightofuse Asset IncreaseDecreaseInRightofuseAsset		usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
	AGRI	Initial Fair Value Of Debenture Warrants Fifth Tranche Warrants InitialFairValueOfDebentureWarrantsFifthTrancheWarrants		usd
	AGRI	Initial Fair Value Of Conversion Feature Of Debentures Fifth Tranche Debentures InitialFairValueOfConversionFeatureOfDebenturesFifthTrancheDebentures		usd
	AGRI	Initial Fair Value Of Debenture Warrants Sixth Tranche Warrants InitialFairValueOfDebentureWarrantsSixthTrancheWarrants		usd
	AGRI	Initial Fair Value Of Conversion Feature Of Debentures Six Tranche Debentures InitialFairValueOfConversionFeatureOfDebenturesSixTrancheDebentures		usd
	AGRI	Initial Fair Value Of Debenture Warrants Seventh Tranche Warrants InitialFairValueOfDebentureWarrantsSeventhTrancheWarrants		usd
	AGRI	Initial Fair Value Of Conversion Feature Of Debentures Seventh Tranche Debentures InitialFairValueOfConversionFeatureOfDebenturesSeventhTrancheDebentures		usd
	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid		usd
CY2024Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent		usd
	us-gaap	Revenues Revenues		usd
	us-gaap	Operating Lease Cost OperatingLeaseCost		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-40578
	dei	Entity Registrant Name EntityRegistrantName	AGRIFORCE GROWING SYSTEMS LTD.
	dei	Entity Address Address Line1 EntityAddressAddressLine1	800 – 525 West 8th Avenue
	dei	Entity Address City Or Town EntityAddressCityOrTown	Vancouver
	dei	Entity Address State Or Province EntityAddressStateOrProvince	BC
	dei	Entity Address Country EntityAddressCountry	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	V5Z 1C6
	dei	City Area Code CityAreaCode	(604)
	dei	Local Phone Number LocalPhoneNumber	757-0952
	dei	Security12b Title Security12bTitle	Common Shares
	dei	Trading Symbol TradingSymbol	AGRI
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	92343334	shares
CY2024Q2	us-gaap	Cash Cash	2937496	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	8479	usd
CY2024Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	25207	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	297609	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	4621	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	3273412	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3574	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	11981175	usd
CY2024Q2	AGRI	Lease Deposit Noncurrent Assets LeaseDepositNoncurrentAssets	78893	usd
CY2024Q2	AGRI	Construction In Progress ConstructionInProgress	111425	usd
CY2024Q2	us-gaap	Investments And Other Noncurrent Assets InvestmentsAndOtherNoncurrentAssets	216263	usd
CY2024Q2	us-gaap	Assets Assets	15664742	usd
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1716274	usd
CY2024Q2	us-gaap	Secured Debt Current SecuredDebtCurrent	925882	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2642156	usd
CY2024Q2	us-gaap	Lease Deposit Liability LeaseDepositLiability	24819	usd
CY2024Q2	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	1630940	usd
CY2024Q2	us-gaap	Long Term Loans Payable LongTermLoansPayable	43837	usd
CY2024Q2	us-gaap	Liabilities Liabilities	4341752	usd
CY2024Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2023Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	84333892	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	84333892	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5841045	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5841045	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	61085023	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2953883	usd
CY2024Q2	AGRI	Obligation To Issue Shares ObligationToIssueShares	86432	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-52067103	usd
CY2024Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-735245	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	11322990	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15664742	usd
CY2023Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1:50 reverse stock split
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	41315	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	41315	usd
CY2024Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	33731	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	33731	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	7584	usd
	us-gaap	Gross Profit GrossProfit	7584	usd
CY2024Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	330616	usd
CY2023Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	798926	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	719220	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1714460	usd
CY2024Q2	AGRI	Consulting Fees Or Expenses ConsultingFeesOrExpenses	83281	usd
CY2023Q2	AGRI	Consulting Fees Or Expenses ConsultingFeesOrExpenses	675905	usd
	AGRI	Consulting Fees Or Expenses ConsultingFeesOrExpenses	186196	usd
	AGRI	Consulting Fees Or Expenses ConsultingFeesOrExpenses	885020	usd
CY2024Q2	us-gaap	Professional Fees ProfessionalFees	159337	usd
CY2023Q2	us-gaap	Professional Fees ProfessionalFees	460984	usd
	us-gaap	Professional Fees ProfessionalFees	329729	usd
	us-gaap	Professional Fees ProfessionalFees	748350	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	285056	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	293768	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	580258	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	629529	usd
CY2024Q2	AGRI	Investor And Public Relations InvestorAndPublicRelations	17366	usd
CY2023Q2	AGRI	Investor And Public Relations InvestorAndPublicRelations	121947	usd
	AGRI	Investor And Public Relations InvestorAndPublicRelations	42646	usd
	AGRI	Investor And Public Relations InvestorAndPublicRelations	389865	usd
CY2024Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	162941	usd
CY2023Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	171839	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	329939	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	340599	usd
CY2024Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	38782	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	205157	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	64122	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	486648	usd
CY2024Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	50598	usd
CY2023Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	61748	usd
CY2024Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	14406	usd
CY2023Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	73194	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	58576	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	149274	usd
CY2024Q2	AGRI	Travel And Entertainment TravelAndEntertainment	3475	usd
CY2023Q2	AGRI	Travel And Entertainment TravelAndEntertainment	28481	usd
	AGRI	Travel And Entertainment TravelAndEntertainment	8158	usd
	AGRI	Travel And Entertainment TravelAndEntertainment	101125	usd
CY2024Q2	AGRI	Shareholder And Regulatory ShareholderAndRegulatory	29485	usd
CY2023Q2	AGRI	Shareholder And Regulatory ShareholderAndRegulatory	8422	usd
	AGRI	Shareholder And Regulatory ShareholderAndRegulatory	85449	usd
	AGRI	Shareholder And Regulatory ShareholderAndRegulatory	78817	usd
CY2024Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	509	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13235	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4094	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	49358	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	1175852	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	2913606	usd
	us-gaap	Operating Expenses OperatingExpenses	2484213	usd
	us-gaap	Operating Expenses OperatingExpenses	5735371	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1168268	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2913606	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2476629	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-5735371	usd
CY2024Q2	AGRI	Accretion Interest On Debentures AccretionInterestOnDebentures	838876	usd
CY2023Q2	AGRI	Accretion Interest On Debentures AccretionInterestOnDebentures	2107808	usd
	AGRI	Accretion Interest On Debentures AccretionInterestOnDebentures	2203081	usd
	AGRI	Accretion Interest On Debentures AccretionInterestOnDebentures	3980278	usd
CY2024Q2	AGRI	Gain Loss On Conversion Of Convertible Debt GainLossOnConversionOfConvertibleDebt	-1119750	usd
CY2023Q2	AGRI	Gain Loss On Conversion Of Convertible Debt GainLossOnConversionOfConvertibleDebt	-13902	usd
	AGRI	Gain Loss On Conversion Of Convertible Debt GainLossOnConversionOfConvertibleDebt	-1392482	usd
	AGRI	Gain Loss On Conversion Of Convertible Debt GainLossOnConversionOfConvertibleDebt	-433605	usd
CY2024Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1887936	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2298369	usd
CY2024Q2	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	716695	usd
CY2023Q2	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	2458993	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	692926	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	5833025	usd
CY2024Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	32121	usd
CY2023Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	33409	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	86752	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	26789	usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	4252	usd
	us-gaap	Inventory Write Down InventoryWriteDown	38470	usd
	AGRI	Write Off Of Deposit WriteOffOfDeposit	12000	usd
CY2024Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	33915	usd
CY2023Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	15942	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	73806	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	54415	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-4232099	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-2526972	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7559799	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4247025	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-128744	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	196119	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-408649	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	311005	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4360843	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2330853	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7968448	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3936020	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.06
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.06
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.32
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-8.72
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-8.72
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	45875887	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	45875887	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	499461	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	499461	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23415625	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23415625	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	487085	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	487085	shares
CY2023Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1:50 reverse stock split
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	8939443	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	6651170	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	62759	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	2624	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	27837	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-4232099	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-128744	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	11322990	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	8564580	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	10624607	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	62759	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	27624	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	11868	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7559799	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-408649	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	11322990	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	8209325	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	695128	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	97837	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	299599	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	204880	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	26000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	107320	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-2526972	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	196119	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	7309236	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	10542653	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	10542653	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1743701	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	203349	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	299599	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	204880	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	53735	usd
	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-2085960	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	283299	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4247025	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	311005	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	7309236	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	7309236	usd
CY2023Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1:50 reverse stock split
	us-gaap	Net Income Loss NetIncomeLoss	-7559799	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4247025	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	329939	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	340599	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	11868	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	283299	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	27624	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	53735	usd
	AGRI	Shares Issued For Compensation SharesIssuedForCompensation	62759	usd
	AGRI	Shares Issued For Compensation SharesIssuedForCompensation	105512	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2149678	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	3808460	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	692926	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	5833025	usd
	AGRI	Gain Loss On Conversion Of Convertible Debt GainLossOnConversionOfConvertibleDebt	-1392482	usd
	AGRI	Gain Loss On Conversion Of Convertible Debt GainLossOnConversionOfConvertibleDebt	-433605	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2298369	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-4252	usd
	AGRI	Write Off Of Deposit WriteOffOfDeposit	12000	usd
	us-gaap	Other Noncash Expense OtherNoncashExpense	97837	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	8479	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-5652	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	12857	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	24737	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-388318	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-34236	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	225000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-225737	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	446943	usd
	AGRI	Increase Decrease In Lease Deposit Asset IncreaseDecreaseInLeaseDepositAsset	18382	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-15336	usd
	AGRI	Increase Decrease In Rightofuse Asset IncreaseDecreaseInRightofuseAsset	57428	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-49825	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2228537	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4339996	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	565741	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	16142	usd
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	2250000	usd
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	4615385	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	802282	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	1741950	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	84463	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	325962	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1363255	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3097072	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations	-75800	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations	-21056	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-941082	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1263980	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3878578	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2269320	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2937496	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1005340	usd
	us-gaap	Interest Paid Net InterestPaidNet	53403	usd
	us-gaap	Interest Paid Net InterestPaidNet	171818	usd
	AGRI	Initial Fair Value Of Debenture Warrants Fifth Tranche Warrants InitialFairValueOfDebentureWarrantsFifthTrancheWarrants	564000	usd
	AGRI	Initial Fair Value Of Conversion Feature Of Debentures Fifth Tranche Debentures InitialFairValueOfConversionFeatureOfDebenturesFifthTrancheDebentures	359000	usd
	AGRI	Initial Fair Value Of Debenture Warrants Sixth Tranche Warrants InitialFairValueOfDebentureWarrantsSixthTrancheWarrants	242000	usd
	AGRI	Initial Fair Value Of Conversion Feature Of Debentures Six Tranche Debentures InitialFairValueOfConversionFeatureOfDebenturesSixTrancheDebentures	198000	usd
	AGRI	Initial Fair Value Of Debenture Warrants Seventh Tranche Warrants InitialFairValueOfDebentureWarrantsSeventhTrancheWarrants	369000	usd
	AGRI	Initial Fair Value Of Conversion Feature Of Debentures Seventh Tranche Debentures InitialFairValueOfConversionFeatureOfDebenturesSeventhTrancheDebentures	297000	usd
	AGRI	Shares Issued For Conversion Of Convertible Debt SharesIssuedForConversionOfConvertibleDebt	10624607	usd
	AGRI	Shares Issued For Conversion Of Convertible Debt SharesIssuedForConversionOfConvertibleDebt	1743701	usd
	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	39875	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_80D_eus-gaap--NatureOfOperations_zDi1ZRVIEPxj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1. <span id="xdx_826_z5hWIcrXi9n5">NATURE OF OPERATIONS AND BASIS OF PREPARATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Business Overview</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AgriFORCE Growing Systems Ltd. (“AgriFORCE™” or the “Company”) was incorporated as a private company by Articles of Incorporation issued pursuant to the provisions of the <i>Business Corporations Act (British Columbia)</i> on December 22, 2017. The Company’s registered and records office address is at 800 – 525 West 8<sup>th</sup> Avenue, Vancouver, British Columbia, Canada, V5Z 1C6.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is an innovative agriculture-focused technology company that delivers reliable, financially robust solutions for high value crops through our proprietary facility design and automation Intellectual Property to businesses and enterprises globally through our AgriFORCE™ Solutions division (“Solutions”) and delivers nutritious food products through our AgriFORCE™ Brands division (“Brands”). During 2023, the Company launched its UN(THINK) Awakened Flour™ flour, which is a nutritious flour that provides many health advantages over traditional flour.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Solutions intends to operate in the plant based pharmaceutical, nutraceutical, and other high value crop markets using its unique proprietary facility design and hydroponics based automated growing system that enable cultivators to effectively grow crops in a controlled environment (“FORCEGH+™”). The Company has designed FORCEGH+™ facilities to produce in virtually any environmental condition and to optimize crop yields to as near their full genetic potential possible whilst substantially eliminating the need for the use of pesticides and/or irradiation. The Company also has a global license to sell and distribute hydroxyl devices. During 2023, the Company completed sales and deliveries of its hydroxyl devices.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brands is focused on the development and commercialization of plant-based ingredients and products that deliver healthier and more nutritious solutions. We will market and commercialize both branded consumer product offerings and ingredient supply.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Basis of Presentation</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying Unaudited Condensed Consolidated Interim Financial Statements and related financial information of AgriFORCE Growing Systems Ltd. should be read in conjunction with the audited financial statements and the related notes thereto for the years ended December 31, 2023 and 2022 included in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on April 1, 2024. These unaudited interim financial statements have been prepared in accordance with the rules and regulations of the United States Securities and SEC for interim financial information. Accordingly, they do not include all of the information and footnotes required by the accounting principles generally accepted in the United States of America (“U.S. GAAP”) for complete financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the opinion of management, the accompanying interim financial statements contain all adjustments which are necessary to state fairly the Company’s financial position as of June 30, 2024 and December 31, 2023, and the results of its operations and cash flows during the six months ended June 30, 2024 and 2023. Such adjustments are of a normal and recurring nature. The results for the six months ended June 30, 2024 are not necessarily indicative of the results to be expected for the full fiscal year ending December 31, 2024, or for any future period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Liquidity and Management’s Plan</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has incurred substantial operating losses since its inception and expects to continue to incur significant operating losses for the foreseeable future. As reflected in the interim financial statements for the six months ended June 30, 2024, the Company had a net loss of $<span id="xdx_905_eus-gaap--NetIncomeLoss_pn5n6_di_c20240101__20240630_z5diAYjBhy9k" title="Net loss">7.6</span> million, $<span id="xdx_90E_eus-gaap--NetCashProvidedByUsedInOperatingActivities_pn5n6_di_c20240101__20240630_zklT5vOQXlOk" title="Net cash used in operating activities">2.2</span> million of net cash used in operating activities, and the Company had working capital of $<span id="xdx_90B_ecustom--WorkingCapitalDeficit_iI_pn5n6_c20240630_ze8dRpeBaJQk" title="Working captial deficit">0.6</span> million.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 24, 2024, the Company received a Staff Listing Determination Letter from Nasdaq pursuant to which the Staff has determined that as of June 21, 2024, the Company’s common shares had a per share closing bid price of $<span id="xdx_908_ecustom--CommonStockClosingBidPrice_c20240606__20240724_z2SFgr64U0Lc" title="Closing bid price">0.10</span> or less for ten consecutive trading days (the Company’s bid price has closed at or below $<span id="xdx_90A_ecustom--CommonStockClosingBidPrice_c20240606__20240724_zLfFdvYC2ykj" title="Closing bid price">0.10</span> per share from June 6, 2024, through June 21, 2024). Nasdaq has granted the Company an exception to comply with the bid price rule as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On or before August 1, 2024, the Company shall obtain Board of Directors approval for a reverse stock split, which was received as of that date;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On or before September 30, 2024, the Company shall obtain shareholders approval for a reverse stock split at a ratio that satisfies the minimum requirement in the Bid Price Rule;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On or before October 9, 2024, the Company shall effect a reverse stock split and, thereafter, maintain a $<span id="xdx_908_ecustom--CommonStockClosingBidPrice_c20241009__20241009__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z29zerSCAdTe" title="Closing bid price">1</span> closing bid price for a minimum of ten consecutive business days;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On or before October 22, 2024, the Company shall have demonstrated compliance with the Bid Price Rule, by evidencing a closing bid price of $<span id="xdx_900_ecustom--CommonStockClosingBidPrice_c20241022__20241022__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zTp4tM0IlUxi" title="Closing bid price">1</span> or more per share for a minimum of ten consecutive trading sessions.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying interim financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The interim financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of this uncertainty. The Company is at the development stage of its business plan. As such it is likely that additional financing will be needed by the Company to fund its operations and to develop and commercialize its technology. These factors raise substantial doubt about the Company’s ability to continue as a going concern. For the next twelve months from issuance of these interim financial statements, the Company will seek to obtain additional capital through the sale of debt or equity financings or other arrangements to fund operations; however, there can be no assurance that the Company will be able to raise needed capital under acceptable terms, if at all. The sale of additional equity may dilute existing shareholders and newly issued shares may contain senior rights and preferences compared to our currently outstanding common shares. If the Company is unable to obtain such additional financing, future operations would need to be scaled back or discontinued. Due to the uncertainty in the Company’s ability to raise capital, management believes that there is substantial doubt in the Company’s ability to continue as a going concern for twelve months from the issuance of these interim financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reverse Stock Split</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 11, 2023, the Company executed a one-for-fifty reverse stock split of the Company’s common shares (the “Reverse Split”). As a result of the Reverse Split, every 50 shares of the Company’s old common shares were converted into one share of the Company’s new common shares. Fractional shares resulting from the reverse split were rounded up to the nearest whole number. The Reverse Split automatically and proportionately adjusted all issued and outstanding shares of the Company’s common shares, as well as convertible debentures, convertible features, prefunded warrants, stock options and warrants outstanding at the time of the date of the Reverse Split. The exercise price on outstanding equity based-grants was proportionately increased, while the number of shares available under the Company’s equity-based plans was proportionately reduced. Share and per share data (except par value) for the periods presented reflect the effects of the Reverse Split. References to numbers of common shares and per share data in the accompanying financial statements and notes thereto for periods ended prior to October 11, 2023 have been adjusted to reflect the Reverse Split on a retroactive basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Net Income Loss NetIncomeLoss	-7600000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2200000	usd
CY2024Q2	AGRI	Working Capital Deficit WorkingCapitalDeficit	600000	usd
CY2024Q3	AGRI	Common Stock Closing Bid Price CommonStockClosingBidPrice	0.10
CY2024Q3	AGRI	Common Stock Closing Bid Price CommonStockClosingBidPrice	0.10
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_84A_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zfTHsjBLmtpe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_zDt6jMvqpQNc">Reclassifications</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has reclassified certain share base payment expenses from <i>Wages and salaries</i> to <i>Share based compensation</i> in the 2023 consolidated statements of comprehensive loss to align with the 2024 presentation.</span></p>
CY2024Q2	AGRI	Legal Retainer LegalRetainer	31547	usd
CY2023Q4	AGRI	Legal Retainer LegalRetainer	8039	usd
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	136157	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	223624	usd
CY2024Q2	AGRI	Inventory Advances InventoryAdvances	110918	usd
CY2023Q4	AGRI	Inventory Advances InventoryAdvances	30654	usd
CY2024Q2	us-gaap	Other Assets Current OtherAssetsCurrent	18987	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	10555	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	297609	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	272872	usd
	AGRI	Write Off Of Deposit WriteOffOfDeposit	12000	usd
CY2024Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	4621	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	38857	usd
CY2023	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	141175	shares
CY2024Q2	AGRI	Unconverted Prefunded Warrants Outstanding UnconvertedPrefundedWarrantsOutstanding	6425	shares
CY2023Q4	AGRI	Unconverted Prefunded Warrants Outstanding UnconvertedPrefundedWarrantsOutstanding	6425	shares
CY2024Q2	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P20Y
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	323816	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	647631	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	647631	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	647631	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	647631	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	647631	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	8419204	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	11981175	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	409147	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	578128	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	875401	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	868451	usd
CY2024Q2	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	431726	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	495432	usd
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1716274	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1942011	usd
CY2023Q3	us-gaap	Debt Instrument Convertible Threshold Trading Days DebtInstrumentConvertibleThresholdTradingDays	5	integer
	us-gaap	Debt Instrument Interest Rate Terms DebtInstrumentInterestRateTerms	The First, Second, Third, Fourth, Fifth, Sixth and Seventh Tranche Debentures (the “Debentures”) have an interest rate of 5% for the first 12 months, 6% for the subsequent 12 months, and 8% per annum thereafter. Principal repayments will be made in 25 equal installments which began on September 1, 2022 for the First Tranche Debentures, July 1, 2023 for the Second Tranche Debentures, January 1, 2024 for the Third Tranche Debentures, May 1, 2024 for the Fourth Tranche Debentures, August 1, 2024 for the Fifth Tranche Debentures, October 1, 2024 for the Sixth Tranche Debentures and November 1, 2024 for the Seventh Tranche Debentures. The Debentures may be extended by nine months at the election of the Company by paying a sum equal to nine months’ interest on the principal amount outstanding at the end of the 18th month, at the rate of 8% per annum.
CY2024Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	2222618	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	7385494	usd
CY2024Q2	us-gaap	Secured Debt Current SecuredDebtCurrent	925882	usd
CY2023Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	4084643	usd
	AGRI	Accretion Interest On Debentures AccretionInterestOnDebentures	2203081	usd
	AGRI	Accretion Interest On Debentures AccretionInterestOnDebentures	3980278	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	802282	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	1741950	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	15336	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	2690308	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	2029000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	-2297316	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	-692926	usd
	AGRI	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Effect Of Exchange Rate Changes FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodEffectOfExchangeRateChanges	-98126	usd
CY2024Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	1630940	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	4649115	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	4022120	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	-194492	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	-5833025	usd
	AGRI	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Effect Of Exchange Rate Changes FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodEffectOfExchangeRateChanges	27893	usd
CY2023Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	2671611	usd
CY2024Q2	us-gaap	Employee Stock Ownership Plan Esop Terms Of Repurchase Obligation EmployeeStockOwnershipPlanESOPTermsOfRepurchaseObligation	Company’s Board of Directors authorized a share repurchase program (the “Repurchase Program”) under which the Company may repurchase up to $1 million of its outstanding common shares, for a period of six months, subject to contractual requirements.
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	47220131	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1202552	shares
	us-gaap	Revenues Revenues	41315	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	145795	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	58576	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	3479	usd
	us-gaap	Lease Cost LeaseCost	58576	usd
	us-gaap	Lease Cost LeaseCost	149274	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	996000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	1800500	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	352000	usd
CY2024Q2	us-gaap	Long Term Debt LongTermDebt	3148500	usd
CY2023Q3	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	451684	usd
CY2023Q3	us-gaap	Loss Contingency Damages Awarded Value LossContingencyDamagesAwardedValue	230000	usd
CY2024Q1	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	467249

Files In Submission

Name	View Source	Status
agri-20240630_cal.xml	Edgar Link	unprocessable
0001493152-24-031696-index-headers.html	Edgar Link	pending
0001493152-24-031696-index.html	Edgar Link	pending
0001493152-24-031696.txt	Edgar Link	pending
0001493152-24-031696-xbrl.zip	Edgar Link	pending
agri-20240630.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
form10-q_001.jpg	Edgar Link	pending
form10-q_002.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
agri-20240630_def.xml	Edgar Link	unprocessable
agri-20240630_lab.xml	Edgar Link	unprocessable
agri-20240630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AGRI
AGRIFORCE GROWING SYSTEMS LTD. Stock $agri

2024 Q3 Form 10-Q Financial Statement

#000149315224031696 Filed on August 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AGRI AGRIFORCE GROWING SYSTEMS LTD. Stock $agri

2024 Q3 Form 10-Q Financial Statement

#000149315224031696 Filed on August 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AGRI
AGRIFORCE GROWING SYSTEMS LTD. Stock $agri